Prosecution Insights
Last updated: August 16, 2026
Application No. 18/897,912

ORGANIC COMPOUND, ORGANIC SEMICONDUCTOR DEVICE, LIGHT-EMITTING DEVICE, AND ELECTRONIC DEVICE

Non-Final OA §102§103
Filed
Sep 26, 2024
Priority
Sep 29, 2023 — JP 2023-170482
Examiner
CHICKS, ASHLI ARIANA
Art Unit
Tech Center
Assignee
Semiconductor Energy Laboratory Co., Ltd.
OA Round
1 (Non-Final)
63%
Grant Probability
Moderate
1-2
OA Rounds
1y 5m
Est. Remaining
99%
With Interview

Examiner Intelligence

Grants 63% of resolved cases
63%
Career Allowance Rate
55 granted / 87 resolved
+3.2% vs TC avg
Strong +46% interview lift
Without
With
+45.9%
Interview Lift
resolved cases with interview
Typical timeline
3y 4m
Avg Prosecution
56 currently pending
Career history
118
Total Applications
across all art units

Statute-Specific Performance

§101
1.6%
-38.4% vs TC avg
§103
28.8%
-11.2% vs TC avg
§102
22.1%
-17.9% vs TC avg
§112
23.9%
-16.1% vs TC avg
Black line = Tech Center average estimate • Based on career data from 87 resolved cases

Office Action

§102 §103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Status Claims 1-15 are pending. Claims 1-11 and 13-15 are rejected. Claim 12 is objected to. Priority Applicant cannot rely upon the certified copy of the foreign priority application because a translation of said application has not been made of record in accordance with 37 CFR 1.55. When an English language translation of a non-English language foreign application is required, the translation must be that of the certified copy (of the foreign application as filed) submitted together with a statement that the translation of the certified copy is accurate. See MPEP §§ 215 and 216. Claim Rejections - 35 USC § 102 The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(2) the claimed invention was described in a patent issued under section 151, or in an application for patent published or deemed published under section 122(b), in which the patent or application, as the case may be, names another inventor and was effectively filed before the effective filing date of the claimed invention. Claim(s) 1-6, and 10-11 are rejected under 35 U.S.C. 102(a)(2) as being anticipated by WO2024039095A1 by Lee et al. The prior art discloses compound 453 which reads on instant claims 1-6, and 10-11 (page 44): PNG media_image1.png 614 578 media_image1.png Greyscale . Regarding instant claims 1-6, the compound is embraced by general formula G1 where each of R1 to R7 is hydrogen, X is an oxygen atom, Ar1 is g1-1, each of R23 to R30 is hydrogen, both R31 and R32 are an unsubstituted alkyl group having 1 carbon atom, each of R8 to R15 is hydrogen, n is 1, R18 is an unsubstituted naphthyl group, and each of R16 to R17 and R19 to R22 is hydrogen. Instant claim 3 provides a conditional limitation for situations when n is greater than or equal to 2, however the claim does not require that n be greater than or equal to 2 therefore the prior art compound is anticipatory. Regarding instant claims 10-11, the compound is embraced by general formula G5 where X is an oxygen atom, both R31 and R32 are an unsubstituted alkyl group having 1 carbon atom, and each of R1 to R11, R16 to R17, R20 to R28, R30, and R49 to R55 are hydrogen. Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claim(s) 1-6, 8, 10-11 and 14 are rejected under 35 U.S.C. 103 as being unpatentable over WO2024039095A1 by Lee et al. Determining the scope and contents of the prior art. (See MPEP § 2141.01) The prior art discloses compound 453 which reads on instant claims 1-6, and 10-11 (page 44): PNG media_image1.png 614 578 media_image1.png Greyscale . Regarding instant claims 1-6, the compound is embraced by general formula G1 where each of R1 to R7 is hydrogen, X is an oxygen atom, Ar1 is g1-1, each of R23 to R30 is hydrogen, both R31 and R32 are an unsubstituted alkyl group having 1 carbon atom, each of R8 to R15 is hydrogen, n is 1, R18 is an unsubstituted naphthyl group, and each of R16 to R17 and R19 to R22 is hydrogen. Instant claim 3 provides a conditional limitation for situations when n is greater than or equal to 2, however the claim does not require that n be greater than or equal to 2 therefore the prior art compound is embraced. Regarding instant claims 10-11, the compound is embraced by general formula G5 where X is an oxygen atom, both R31 and R32 are an unsubstituted alkyl group having 1 carbon atom, and each of R1 to R11, R16 to R17, R20 to R28, R30, and R49 to R55 are hydrogen. Lee et al. disclose a light emitting device comprising the compound as required by instant claims 8 and 14 (page 3 of translation). Ascertainment of the differences between the prior art and the claims. (See MPEP § 2141.02) The prior art compound reads on instant claims 1-6 and 10-11. Regarding instant claims 8 and 14, Lee et al. teach a light emitting device comprising the compound however Lee et al. do not disclose an embodiment where the device was produced with the compound above. Finding of prima facie obviousness --- rationale and motivation (See MPEP § 2142-2143) A person of ordinary skill seeking to use the prior art compound in the disclosed utility would have been motivated to prepare a light emitting device comprising compound 453 as suggested by Lee et al. Claim(s) 7, 9, 13 and 15 are rejected under 35 U.S.C. 103 as being unpatentable over WO2024039095A1 by Lee et al. as applied to claims 1-6, 8, 10-11 and 14 above, and further in view of CN 115141108 A by Kubota et al. Lee et al. suggest that the prior art compound may function in organic electronic devices but do not discuss semiconductor devices (page 34 of translation). Kubota et al. teach light emitting devices and compounds analogous to the compound of Lee et al. The following compound of Kubota et al. is an example of an analogous compound corresponding to general formulas G1 and G5, where the compound has a nitrogen bound to a fluorophene ring, phenyl substituted by an additional aryl group, and a second three-ring condensed cycle (page 17): PNG media_image2.png 280 286 media_image2.png Greyscale . Regarding instant claims 7, 13, and the use of the prior art compounds, Kubota et al. teach (pages 13 and 21): One embodiment of the present invention can provide a novel organic compound having carrier transport properties. One embodiment of the present invention can provide a novel organic compound having hole transport properties. (page 13) An organic semiconductor device with easy hole injection and low driving voltage can be realized by adopting a structure in which the organic semiconductor device includes at least two layers (a first hole transport layer, a second hole transport layer) stacked in contact with each other, When holes flow from the first hole transport layer side to the second hole transport layer side, the GSP (GSP1) of the organic compound constituting the first hole transport layer and the organic compound constituting the second hole transport layer are The difference between GSP(GSP2), ΔGSP(GSP2-GSP1), is a positive value. Therefore, in this case, the organic compound of one embodiment of the present invention can be appropriately used for the first hole transport layer. (page 21) The prior art further teaches “displays and lighting devices using light-emitting devices are suitable for use in various electronic devices” wherein Kubota et al. provide an embodiment for a light-emitting device and a light-receiving device that can be used in a display device (page 7; page 56, Embodiment 8). Kubota et al. teach that the active layer of the light-receiving device contains an organic semiconductor device in accordance with instant claims 9 and 15 (page 57). Accordingly, a person of ordinary skill in the art would have been motivated to produce electronic devices such as one containing the semiconductor of Kubota et al. and would be motivated to test the device with the analogous compound of Lee et al. in the hole transport layer to optimize performance of the device. Allowable Subject Matter Claim 12 is objected to as being dependent upon a rejected base claim, but would be allowable if rewritten in independent form including all of the limitations of the base claim and any intervening claims. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to ASHLI A CHICKS whose telephone number is (571)270-0582. The examiner can normally be reached M-Th 7 a.m.- 5 p.m.. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, James H Alstrum-Acevedo can be reached at (571)272-5548. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /A.A.C./Examiner, Art Unit 1626 /MATTHEW P COUGHLIN/Primary Examiner, Art Unit 1626
Read full office action

Prosecution Timeline

Sep 26, 2024
Application Filed
Oct 29, 2025
Response after Non-Final Action
Jul 14, 2026
Non-Final Rejection mailed — §102, §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12679842
HCK AS A THERAPEUTIC TARGET IN MYD88 MUTATED DISEASES
4y 3m to grant Granted Jul 14, 2026
Patent 12662470
HYDROXY AND (HALO)ALKOXY SUBSTITUTED TETRAHYDROFURANS AS MODULATORS OF SODIUM CHANNELS
2y 6m to grant Granted Jun 23, 2026
Patent 12653808
COMPOUNDS FOR TREATING MULTIPLE MYELOMA
5y 0m to grant Granted Jun 16, 2026
Patent 12612426
Aryl Glucoside Derivative
3y 2m to grant Granted Apr 28, 2026
Patent 12612382
PROCESS FOR PREPARING 6-SUBSTITUTED-1-(2H)-ISOQUINOLINONES AND INTERMEDIATE COMPOUND
2y 0m to grant Granted Apr 28, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
63%
Grant Probability
99%
With Interview (+45.9%)
3y 4m (~1y 5m remaining)
Median Time to Grant
Low
PTA Risk
Based on 87 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month